Comment on “Efficacy and safety of antihypertensive drugs deprescribing in older adults: A systematic review and meta-analysis of randomized controlled trials”
Sambit Kumar Parida, Mohit Kotnala, Suraj Mandal · 2026
Read Comment on “Efficacy and safety of antihypertensive drugs deprescribing in older adults: A systematic review and meta-analysis of randomized controlled trials” by Sambit Kumar Parida, Mohit Kotnala, Suraj Mandal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13329373.txt.
Description
Sambit Kumar Parida, Mohit Kotnala, and Suraj Mandal comment in 2026 on a review of stopping blood pressure drugs in older adults. The review pooled four trials with 2,173 patients and found no clear rise in deaths or falls. The comment argues that calling those results reassuring goes too far.
Wide ranges around the estimates leave room for real harm, the authors note, and certainty for many outcomes was rated very low. The four trials also enrolled very different groups, from fit community dwellers to frail nursing home residents with severe dementia. A plan that is safe for one group may not suit another. The comment urges care matched to each patient group.
Catalog record
| CREATOR | Sambit Kumar Parida, Mohit Kotnala, Suraj Mandal |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6065 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |